In the second of a two-part roundtable series, Manufacturing Chemist speaks to a selection of leaders in the CMO space to uncover the opportunities for growth and development in the sector, and the trends that will influence the future of contract manufacturing.
MC: What is the greatest challenge currently faced by contract manufacturers?
Manuel Leal, Idifarma: A very relevant challenge is to reconcile the growing regulatory requirements with the pressure on price coming from “payers” and clients, which is especially important for high-volume products manufactured by big CMOs. The need to adapt to the new serialisation requirements coming to the EU in 2019 will also be a challenge for large CMOs in terms of resources and investments. Smaller CMOs focused on more niche and complex product manufacturing will be less exposed to those challenges.
Not yet a Subscriber?
This is a small extract of the full article which is available ONLY to premium content subscribers. Click below to get premium content on Manufacturing Chemist.
Subscribe now Already a subscriber? Sign in here.
Featured companies
- Companies:
- Recipharm
- Saneca Pharmaceuticals
- Idifarma Desarrollo Farmacéutico
- Sterling Pharma Solutions
